The CompassHER2 pCR Trial protocol has been amended to include the evaluation of the HER2DX ® genomic test as a key secondary endpoint. HER2DX ® pCR-score and HER2DX ® risk-score will be analyzed in ...

Phase 1 trial of SHR-A2102, a nectin-4–directed antibody drug conjugate (ADC), in advanced solid tumors. Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A ...

An open-label single-center investigator-initiated exploratory clinical study in patients with refractory or recurrent solid tumors using SBRT as “in situ vaccination”: R-ISV-FOLactis trial. This is ...

The next frontier in cancer detection could be the humble urine test. Emerging science suggests that the body's "liquid gold" could be particularly useful for liquid biopsies, offering a convenient, ...

Traditionally, test developers have used quantitative PCR (qPCR) to create highly specific laboratory-developed tests (LDTs). However, digital PCR (dPCR) is emerging as the preferred technology for ...

A new diagnostic tool developed by researchers can test for SARS-CoV-2 and Zika virus with the same or better accuracy as high-precision PCR tests in a matter of hours. Over the past four years, many ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), and Gencurix, Inc. (KOSDAQ: 229000), announced the signing of a strategic agreement establishing Bio-Rad as the exclusive distributor of Gencurix’ ...

A video advocating for an airline that vows to resist any future COVID-19 restrictions such as requirements to be vaccinated, wear a face mask, or provide a negative COVID-19 test, contains false ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.